Prostate Cancer - Results from #2640

Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022. June 13, 2023

Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting June 13, 2023

Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare June 12, 2023

Artificial intelligence applications in prostate cancer. June 12, 2023

Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer Patients. June 12, 2023

Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). June 12, 2023

Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer. June 12, 2023

Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer. June 12, 2023

Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research. June 12, 2023

Minor Intron Splicing Is Critical for Survival of Lethal Prostate Cancer June 11, 2023

Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015. June 9, 2023

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial. June 9, 2023

Testosterone treatment and change of categories of the International prostate symptom score (IPSS) in hypogonadal patients: 12 years prospective controlled registry study. June 9, 2023

PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal. June 9, 2023

The genomic and epigenomic landscape of double-negative metastatic prostate cancer. June 9, 2023

Potential margin reduction in prostate cancer proton therapy with prompt gamma imaging for online treatment verification. June 9, 2023

ZERO Prostate Cancer Taps Breast Cancer Leader and Survivor as Next President and CEO June 8, 2023

PET imaging of new target CDK19 in prostate cancer. June 8, 2023

Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. June 8, 2023

Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer. June 8, 2023

Page 133 of 1439